Videos

PARP Inhibition Improves Outcomes in Patients With BRCA-Mutated Ovarian Cancer

May 29, 2020

David O'Malley, MD, discusses the role of PARP inhibitors in the treatment landscape of ovarian cancer.

A 68-Year-Old Woman With Stage IV Ovarian Cancer

May 29, 2020

Ramez Eskander, MD, presents the case of a 68-year-old woman with stage IV ovarian cancer, and discusses the management approach for this patient and similar cases.

How Different Factors Affect Treatment of Endometrial Cancer

May 28, 2020

Brian M. Slomovitz, MD, discusses the some of the subcategories of endometrial cancer and how the make a difference for patients’ treatment.

Evaluating Future Steps for Investigating Seleno-L-Methionine in RCC

May 28, 2020

Yousef Zakharia, MD, discusses the next steps after the phase 1 trial of seleno-L-methionine in combination with axitinib as treatment of adult patients with previously treated or relapsed clear cell renal cell carcinoma.

Treatments Improve PFS in Thyroid Cancer

May 28, 2020

Winston Tan, MD, discusses 2 agents that have advanced the treatment landscape for patients with thyroid cancer, including the multi-tyrosine kinase inhibitor lenvatinib and another TKI, sorafenib.

A 69-Year-Old Woman With Follicular Lymphoma

May 28, 2020

Ajay K. Gopal, MD, discusses the rationale for treating a 69-year-old woman with high-risk follicular lymphoma with a PI3-kinase inhibitor in the third-line setting.

Experts Discuss How COVID-19 Has Impacted Gynecologic Oncology Practices

May 27, 2020

A group of physicians in gynecologic oncology spoke to the challenges they have seen in their clinics in the face of the COVID-19 pandemic.

The Importance of IMspire150 Data Is Questioned in Melanoma Treatment Landscape

May 27, 2020

Charles L. Sawyers, MD, discusses the value of atezolizumab, cobimetinib, and vemurafenib in the melanoma treatment landscape.

Targeting KRAS Mutations in Advanced NSCLC

May 27, 2020

Shared insight on recent advances in KRAS-mutant NSCLC, with a focus on new therapies on the horizon.

Challenges Remain in Conducting Clinical Trials for Patients With Cervical Cancer

May 27, 2020

Bradley J. Monk, MD, FACS, FACOG, discusses the remaining challenges in conducting clinical trials for patients with cervical cancer.